An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control
Abstract CD73, an ectoenzyme responsible for adenosine production, is often elevated in immuno-suppressive tumor environments. Inhibition of CD73 activity holds great promise as a therapeutic strategy for CD73-expressing cancers. In this study, we have developed a therapeutic anti-human CD73 antibod...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55207-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|